Colchicine and Quality of Life in Patients With Acute Coronary Syndromes: Results From the COPS Randomized Trial
Abstract
Background
Recent data suggest that colchicine may reduce cardiovascular events among patients presenting with acute coronary syndromes. This sub-study of the Australian COPS trial aimed to assess whether colchicine affects health status outcomes.